Abstract

Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution

Author(s): Kommanaboyina Brahmaiah, Lindauer Richard F, Rhodes Christopher T, Grady Lee T

Issue: Mar/Apr 2000 - Compounding for Diabetes Patients

Page(s): 146-149

Download in electronic PDF format for $75
  • Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution Page 1
  • Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution Page 2
  • Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution Page 3
  • Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution Page 4

Abstract

The chemical stability of three compounded batches of cefazolin ophthalmic solution was monitored by a stability-indicating high-performance liquid chromatography assay. The degradation was governed by first-order kinetics, and the effect of temperature on reaction rate was in accordance with the Arrhenius equation at and above 17°C. Although the stability of all three batches was essentially the same, buffering the formulations may be useful. Even using a most cautious and conservative approach to the assignment of a beyond-use date for this type of product, it appears that, if the product is stored at controlled room temperature, a beyond-use date of six days would be fully justifiable. If the product is stored in a refrigerator, then a beyond-use date of 14 days could be assigned.

Related Keywords

  • degradation

Related Categories

  • OPHTHALMICS
  • PEER-REVIEWED
  • STABILITIES, COMPATIBILITIES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2000
Pg. 146-149
Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution
Author(s): Kommanaboyina Brahmaiah, Lindauer Richard F, Rhodes Christopher T, Grady Lee T
Sep/Oct 2016
Pg. 399-404
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
Sep/Oct 2010
Pg. 421
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Author(s): Allen Loyd V Jr
Nov/Dec 2017
Pg. 481-486
Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Author(s): Allen Loyd V Jr
Jan/Feb 2016
Pg. 41-45
Formulation and Stability of Solutions
Author(s): Akers Michael J
Jan/Feb 2025
Pg. 51
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Author(s):
Jul/Aug 2001
Pg. 300
Cefazolin Ophthalmic Solution, USP 0.35- mg/mL
Author(s): Allen Loyd V Jr
Mar/Apr 2018
Pg. 129-134
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy
Author(s): Rhoads Rick
Sep/Oct 2003
Pg. 389-393
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Author(s): Alexander Kenneth S, Thyangarajapuram N
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Jul/Aug 1999
Pg. 316-320
Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution
Author(s): Peyron Florence, Elias R, Ibrahim E, Amirat-Combralier V, Bues-Charbit M, Balansard G
Jan/Feb 2009
Pg. 32-36
Identifying the Criteria of a Valid Stability Study
Author(s): Williams LaVonn A, Hastings Mitchell Blaine
Jul/Aug 2000
Pg. 320-323
Stability of 5-Fluorouracil in an Extemporaneously Compounded Ophthalmic Solution
Author(s): Fuhrman L Clifton, Godwin Donald A, Davis R Alan
Nov/Dec 2016
Pg. 495-500
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Author(s): Allen Loyd V Jr
Jul/Aug 2021
Pg. 324
Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution
Author(s): Allen Loyd V Jr
Nov/Dec 2015
Pg. 508
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate
Author(s): Allen Loyd V Jr
Mar/Apr 2003
Pg. 152-154
Chemical Stability of Cefazolin Sodium after Reconstituting in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Author(s): Gupta Vishnu D
Sep/Oct 2014
Pg. 427-431
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition
Author(s): Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard